Effect of SNPs on OPs. Age and race variations explored.
Freeman
Kris
K
D000328:Adult; D000367:Age Factors; D043303:Aryldialkylphosphatase / Q000235:genetics* / Q000378:metabolism; D002657:Child Development / Q000187:drug effects; D004390:Chlorpyrifos / Q000009:adverse effects / Q000493:pharmacokinetics; D005260:Female; D005838:Genotype; D006801:Humans; D008658:Inactivation, Metabolic / Q000235:genetics; D007231:Infant, Newborn; D007306:Insecticides / Q000009:adverse effects / Q000493:pharmacokinetics*; D018811:Maternal Exposure; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D044469:Racial Groups / Q000235:genetics
D007306:Insecticides; D043303:Aryldialkylphosphatase; C468406:PON1 protein, human; D004390:Chlorpyrifos